Study on weight loss types in advanced cancer
Part of Cancer, Digestive system, Hormones & metabolism, Lungs & breathing clinical trials.
This study looks at different types of weight loss (cachexia) in people with advanced lung, pancreatic, or colorectal cancer. Researchers want to find patterns to better understand and treat it. You can join even if you haven't lost weight yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced (stage 4 or not removable by surgery) non-small cell lung cancer, pancreatic cancer, or colorectal cancer.
- You are about to start your first cancer treatment (like chemo, immunotherapy, or targeted therapy) within the next 6 weeks, or you started it in the last 6 weeks.
- You are 18 years or older.
- You can understand, speak, and read English.
- You are able to do simple physical tests like arm curls, standing up from a chair, or a timed walk.
- You are not pregnant.
- You have not had major surgery planned in the next 3 months.
- You have not had chemotherapy or surgery for another cancer (except early skin cancer) in the past 3 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how weight loss and muscle loss affect people with advanced cancer. It aims to find different types of weight loss to better guide treatment and care.
This trial tests whether a postbiotic supplement can help people with advanced non-small-cell lung cancer who are losing weight (cachexia). If you're getting or have finished chemotherapy plus immunotherapy for stage III or IV NSCLC and have lost weight recently, you may be able to join.
This trial tests a new appetite-boosting medicine (nano-crystalline megestrol acetate) added to standard chemotherapy for people with advanced small cell lung cancer who are losing weight. It aims to see if it helps with weight, strength, and treatment response.
This study looks at how a person’s genetic variations may relate to cancer-related weight loss (cachexia) in pancreatic cancer. It may help researchers better understand who is most at risk and guide future treatments.
This study looks at why cancer can cause loss of muscle in people with advanced non–small cell lung cancer, and whether exercise can improve or explain those muscle changes. You may be asked to do physical testing and answer questionnaires while receiving standard palliative cancer treatment.
This study explores why certain cancers cause patients to lose weight and muscle (called cancer cachexia) and tests ways to reverse it. Researchers will study tissue samples from patients with cancers of the food pipe, liver, stomach, or bile ducts to understand what's happening at a cellular level.
Hear when a new Advanced Colorectal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.